Clinical trial
Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate
NCT05750576 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 15, 2023
- Completion date
- June 20, 2025
- Enrollment
- 270 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
acute respiratory distress syndrome, cardiogenic shock, extracorporeal membrane oxygenation complication, infections